Case Study 1: Caffeine intake during pregnancy: impact on national guidance
Submitting Institution
University of LeedsUnit of Assessment
Agriculture, Veterinary and Food ScienceSummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Clinical Sciences, Nutrition and Dietetics, Paediatrics and Reproductive Medicine
Summary of the impact
Caffeine is widely consumed in pregnancy as has the potential to harm the
developing fetus. Professor Janet Cade and colleagues at the
University of Leeds designed a robust study to accurately quantify
caffeine intake in 2635 pregnant women throughout pregnancy. The results
showed caffeine intake is associated with an increased risk of fetal
growth restriction, which is linked with perinatal mortality and morbidity
and adverse effects in later life. As a result of this study, and a review
of previous evidence, the Food Standards Agency issued new advice to
pregnant women to limit their daily caffeine intake to below 200mg/day.
Underpinning research
Animal studies had suggested that consumption of caffeine during
pregnancy could harm the developing fetus but research in humans had
proven inconclusive, largely due to inconsistencies in study methodology
and difficulties in accurately assessing caffeine intake or the effect of
variation in caffeine metabolism.
In 2001, the UK Committee on Toxicity of Chemicals in Food (COT) reviewed
the evidence and concluded that caffeine intake of more than 300mg/day
might be associated with low birth weight and spontaneous miscarriage but
that more rigorous work was needed.[1]
After an initial competitive round of submissions, a team at the
University of Leeds (Janet Cade, Professor of Nutritional
Epidemiology; Alastair Hay, Professor of Environmental Toxicity; Darren
Greenwood, Senior Lecturer in Biostatistics) was commissioned in
2003 by the Food Standards Agency (FSA) to design and conduct the Caffeine
and Reproductive Health (CARE) study — a multicentre prospective,
longitudinal observational project based in two large maternity hospitals
in Leeds and Leicester — to determine the safe upper limit of caffeine
consumption in pregnancy.
To more accurately ascertain caffeine intake, Cade developed a
validated caffeine assessment tool which was designed to record habitual
caffeine consumption before and after pregnancy and from all potential
dietary sources and over-the-counter drugs, not just from coffee or tea,
as in many previous studies.[2] Specific brand names, portion sizes,
preparation methods and quantity and frequency of intake at different
periods of gestation were recorded. Precise caffeine intakes were then
calculated using a program the Leeds group designed.[2]
Hay also developed a novel saliva test for determining the
half-life of caffeine, which enabled the team to take into account
individual variations in metabolism.
Together both centres recruited a total of 2635 low risk, pregnant women
between 8-12 weeks of pregnancy who recorded total caffeine intake from
four weeks before conception and throughout pregnancy as well as potential
confounding factors such as alcohol and smoking, with nicotine
concentrations confirmed with saliva cotinine tests.
The study showed that caffeine consumption throughout pregnancy was
associated with a significantly increased risk of fetal growth restriction
as defined by customised birthweight centile (taking account of factors
such as maternal height, weight and ethnicity), and adjusted for alcohol
intake and salivary cotinine concentrations (Greenwood).[3]
Women with caffeine intakes 300mg/day or more had a 40% increased risk of
having a growth-restricted baby compared with those with intakes of less
than100mg/day. Caffeine consumption of 200mg/day was associated with a
reduction in birth weight of about 60-70g, a similar size of effect to
that seen for alcohol intake in pregnancy.[3]
The study also found a strong association between caffeine intake in the
first trimester and subsequent late miscarriage and stillbirth. Compared
with those consuming less than 100 mg/day of caffeine, there was a 2.2
times higher risk for those consuming 100-199 mg/day, 1.7 times higher
risk for 200-299 mg/day, and 5.1 times higher risk for 300mg/day or
more.[4]
After further analysis, no evidence was found that the relationship
between maternal caffeine intake and fetal growth restriction was modified
by nausea and vomiting in pregnancy.[5]
References to the research
2. Boylan SM, Cade JE, Kirk SFL, Greenwood DC, White KLM, Shires
S, Simpson NAB, Wild CP and Hay AWM. Assessing caffeine exposure in
pregnant women. British Journal of Nutrition 2008 ; 100: 875-882.
10.1017/S0007114508939842 [doi]
3. CARE Study Group. Maternal caffeine intake during pregnancy and risk
of fetal growth restriction: a large prospective observational study. BMJ
2008 ; 337: a2332. 10.1136/bmj.a2332 [doi]
4. Greenwood DC, Alwan N, Boylan S, Cade JE, Charvill J, Chipps
KC, Cooke MS, Dolby VA, Hay AW, Kassam S, et al. Caffeine intake during
pregnancy, late miscarriage and stillbirth. Eur J Epidemiol 2010;
25:275-80. 10.1007/s10654-010-9443-7 [doi]
5. Boylan SM, Greenwood DC, Alwan N, Cooke MS, Dolby VA, Hay AW, Kirk SF,
Konje JC, Potdar N, Shires S, Simpson NA, Taub N, Thomas JD, Walker JJ,
White KL, Wild CP, Cade JE. Does nausea and vomiting of pregnancy
play a role in the association found between maternal caffeine intake and
fetal growth restriction? Matern. Child Health J. 2013; 17: 601-608.
10.1007/s10995-012-1034-7 [doi]
Details of the impact
Most pregnant women in the UK and elsewhere consume caffeine from one or
more sources yet before the current work the evidence of any harm to the
fetus was inconclusive and a level at which harm may occur was unclear.
The CARE study overcame several limitations seen in previous studies. Cade
developed a tool to accurately calculate an individual's caffeine intake
from all potential dietary and over-the-counter sources, taking into
account brands and preparation, rather than just a tally of coffee and tea
consumption. The Leeds research also looked at the effects of caffeine
consumption across all trimesters and prior to conception, rather than
just a snapshot at one point in pregnancy.
In addition, the study took into account individual variations in
caffeine metabolism that can show marked differences due to genetics, but
also environmental factors such as nicotine.
Impact on public awareness of health risk
This robust study design showed that caffeine consumption during
pregnancy is associated with an increased risk of fetal growth restriction
at levels of 200mg/day and maybe even lower and that the association
continues throughout the whole of pregnancy.[3]
Fetal growth restriction is an important outcome as it is associated with
an increased risk of perinatal mortality and morbidity.[A] In addition,
there is epidemiological evidence that it correlates with adverse effects
in adult life. For example, affected individuals have an increased
incidence of metabolic syndrome, manifesting as obesity, hypertension,
hypercholesterolemia, cardiovascular disease, and type 2 diabetes.
Clearly, reducing the risk of perinatal morbidity and mortality through
impact on birthweight is important for the long-term health and survival
of every child.[B]
These results meant that for the first time women could be provided with
clear evidence and advice to reduce their caffeine intake before
conception and during the whole of pregnancy.
Further analysis led by Greenwood and published in 2010 showed a strong
link between caffeine consumption in the first trimester and late
miscarriage and stillbirth, further proving the harm associated with
caffeine in pregnancy.[4]
Impact on public policy and services
In 2008, the team presented their results to COT who, in light of the
evidence, decided to review their guidance and publish new recommendations
to coincide with the publication of the CARE study.
A statement (in 2008) from COT, explicitly referring to the research at
Leeds, concluded that while it seems likely that risk of fetal growth
restriction is increased in association with caffeine intakes in the order
of 200 mg/day and perhaps even lower, the absolute increase in incidence
of fetal growth restriction from intakes less than this is likely to be
less than 2% of infants.[C]
The FSA issued (in 2008) updated guidelines to women to limit their daily
caffeine intake to below 200mg/day, the equivalent to two mugs of coffee,
although caffeine is also present in tea, chocolate, some soft drinks, and
certain medicines.[D] The previous advice had set a maximum daily intake
of 300mg.
This new advice, along with results from the CARE study, was featured in
national news reports in both the print and broadcast media, including BBC
News Online, The Times, Daily Mail and The Daily Telegraph.[E] Professor Cade
briefed key stakeholders prior to publication of the study and the FSA
guidance.
The revised guidelines were taken up by the NHS[F] and included in the
Pregnancy Book, which is a highly trusted source of advice handed out to
all pregnant women (ca. 700,000 per year) England.[G] The NHS Choices
website also contains these recommendations.[H]
Through the direct impact of this work — on the advice given to pregnant
women — all families have the potential to benefit from this research.
Moreover, healthcare providers including, GPs, obstetricians and midwives
have clearer guidance for delivering appropriate prenatal care. The Royal
College of Obstetricians and Gynaecologists issued a statement to
highlight the updated advice.[I]
Data on the potential impact of the advice on caffeine intake in pregnant
women for the relevant time period is not yet available. However, it is
known that two thirds of infants who die have a low birth weight. Data
from the Office for National Statistics show that for 2008-2010 the drop
in infant mortality in England and Wales was significantly steeper than
for the previous years at 4.5/1000 live births compared with4.8/1000 live
births in 2006-2008.[J] While this reduction in the infant mortality rate
cannot solely be attributed to changing patterns of behaviour during
pregnancy in relation to caffeine, we are not aware of other guidance
directed at pregnant women during this time, that would have contributed
to this steeper rate of decline.
Sources to corroborate the impact
[A] Bryant AS, Worjoloh A, Caughey AB, Washington AE. Racial/ethnic
disparities in obstetric outcomes and care: prevalence and determinants.
Am. J. Obstet. Gynecol. 2010 Apr;202(4):335-43. doi:
10.1016/j.ajog.2009.10.864 [doi]
[B] Saigal, S and Doyle, LW. An overview of mortality and sequelae of
preterm birth from infancy to adulthood, The Lancet, 2008, 371: 261-269.
[C] Committee on Toxicity of Chemicals in Food, Consumer Products and the
Environment. Statement on Reproductive Effects of Caffeine. 2008
http://cot.food.gov.uk/pdfs/cotstatementcaffeine200804.pdf
[D] Food Standards Agency press release on new caffeine advice for
pregnant women. 2008
http://tna.europarchive.org/20111116080332/http://www.food.gov.uk/news/pressreleases/2008/nov
/caffeineadvice
[E] The Times, 03/11/2008, Pregnant women told to drink no more than
two cups of coffee a day. BBC News Online, 03/11/2008 Cut
caffeine, pregnant women told. Daily Mail, 03/11/2008 Two cups
of coffee a day can lead to underweight babies, experts claim.The
Daily Telegraph 03/11/2008Caffeine link to under-weight babies prompts
cut to government coffee guidelines.
[F] NHS Choices. Advice on caffeine during pregnancy.http://www.nhs.uk/chq/Pages/limit-caffeine-during-pregnancy.aspx
[G] Department of Health. The Pregnancy Book, 2009. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_107302
[H] NHS Choices. Foods to avoid in pregnancy. http://www.nhs.uk/conditions/pregnancy-and-
baby/pages/foods-to-avoid-pregnant.aspx#Caffeine
[I] Royal College of Obstetricians and Gynaecologists. RCOG statement on
FSA guidance on caffeine consumption during pregnancy (3/11/2008). http://www.rcog.org.uk/what-we-
do/campaigning-and-opinions/statement/rcog-statement-fsa-guidance-caffeine-consumption-durin
[J] Office for National Statistics. Data on infant mortality http://neighbourhood.statistics.gov.uk/dissemination/hierarchySelection.do?step=3&datasetFamilyI
d=1700&instanceSelection=026920&hierarchyId=2&rightPaneBoxHeight=497&JSAllowed=true&br
owserHeight=674&browserWidth=1206&%24ph=60_61_62&CurrentPageId=62&Back.x=10&Back.
y=9